Coagulants and Anti-Coagulants
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
RIVAROXABAN: products 41 to 48 of 48.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Teva-Rivaroxaban 10mg TabDIN 02507196 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
| Teva-Rivaroxaban 15mg TabDIN 02507218 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
| Teva-Rivaroxaban 2.5mg TabDIN 02547295 | General benefit | $0.3550per source unit | Requirements & sourcesBuild cost plan |
| Teva-Rivaroxaban 20mg TabDIN 02507226 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
| Xarelto 10mg TabDIN 02316986 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
| Xarelto 15mg TabDIN 02378604 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
| Xarelto 2.5mg TabDIN 02480808 | General benefit | $0.3550per source unit | Requirements & sourcesBuild cost plan |
| Xarelto 20mg TabDIN 02378612 | General benefit | $0.7175per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
20:12 Coagulants and Anti-Coagulants.
20:12:04 Direct Factor Xa Inhibitors.
20:12:16 Hemostatics.